Handelsbanken Fonder’s Immunogen Inc IMGN Stock Holding History

Handelsbanken Fonder’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-48,700	Closed	-$1.44M	–	1581
2023 Q4	$1.44M	Buy	48,700 +4,600	+10%	+$91.6K	0.01%	653
2023 Q3	$700K	Buy	44,100 +9,100	+26%	+$151K	﹤0.01%	892
2023 Q2	$660K	Buy	35,000 +6,800	+24%	+$80.3K	﹤0.01%	929
2023 Q1	$108K	Hold	28,200	–	–	﹤0.01%	1523
2022 Q4	$140K	Buy	28,200 +11,400	+68%	+$61.8K	﹤0.01%	1482
2022 Q3	$80K	Sell	16,800 -25,000	-60%	-$132K	﹤0.01%	1545
2022 Q2	$188K	Sell	41,800 -1,500	-3%	-$6.52K	﹤0.01%	1508
2022 Q1	$206K	Hold	43,300	–	–	﹤0.01%	1627
2021 Q4	$321K	Hold	43,300	–	–	﹤0.01%	1596
2021 Q3	$246K	Hold	43,300	–	–	﹤0.01%	1624
2021 Q2	$285K	Buy	+43,300	New	+$302K	﹤0.01%	1636

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Handelsbanken Fonder's IMGN Position: Q1 2024 in Review

Handelsbanken Fonder sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 48,700 shares — an estimated $1.44M sold.

Handelsbanken Fonder first reported a position in IMGN in Q2 2021 and held it in 11 quarters. The position peaked at $1.44M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Handelsbanken Fonder reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Handelsbanken Fonder sold 48,700 Immunogen Inc shares in Q1 2024, an estimated $1.44M.
Handelsbanken Fonder first reported a position in Immunogen Inc in Q2 2021 and held it in 11 quarters.
Handelsbanken Fonder's Immunogen Inc position peaked at $1.44M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Handelsbanken Fonder's 13F filing for Q1 2024, filed 13 May 2024.